Literature DB >> 32977263

Association between depression and nonalcoholic fatty liver disease: Contributions of insulin resistance and inflammation.

Ju Won Lee1, Seung Ha Park2.   

Abstract

BACKGROUND: It is unclear whether depression is linked to nonalcoholic fatty liver disease (NAFLD). The purpose of this study was to examine the association between depression and NAFLD and whether the association is partly explained by insulin resistance or inflammation.
METHODS: Subjects consisted of 4,688 adults who participated in the 2016 Korea National Health and Nutrition Examination Survey. Depression was defined by Patient Health Questionnaire-9 score ≥ 10 or a previous diagnosis of depression. NAFLD was defined by hepatic steatosis index >36. Insulin resistance was assessed by triglycerides and glucose (TyG) index. Inflammation was measured with C-reactive protein (CRP).
RESULTS: Depression had a significant association with TyG index (p = 0.005), but not with CRP. Depression was a significant predictor of NAFLD (OR = 1.63; 95% CI, 1.26-2.10; p < 0.001). Adjustment for sociodemographic features and waist circumference did not substantially affect the results. Further adjustment for comorbidities reduced the estimate for depression by 23% (OR = 1.56; 95% CI, 1.18-2.06; p = 0.002). Inclusion of CRP in a fully adjusted model did not affect the results. Addition of the TyG index decreased the estimate for depression by 28% (OR = 1.39; 95% CI, 0.88-2.19; p = 0.161), and the resulting estimate became no longer significant. The TyG index remained the independent predictor of outcome. LIMITATIONS: The absence of a structured diagnostic interview for depression and histological diagnosis of NAFLD.
CONCLUSIONS: These data support an association of depression with NAFLD. Insulin resistance seems to play a major role in modulating the association between depression and NAFLD risk.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Depression; Inflammation; Insulin resistance; Non-alcoholic fatty liver disease

Mesh:

Year:  2020        PMID: 32977263     DOI: 10.1016/j.jad.2020.09.073

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  4 in total

1.  The association between major dietary patterns with the risk of non-alcoholic fatty liver disease, oxidative stress and metabolic parameters: A case-control study.

Authors:  Fateme Moradi; Seyedeh Parisa Moosavian; Farhang Djafari; Azam Teimori; Zahra Faghih Imani; Amirmansour Alavi Naeini
Journal:  J Diabetes Metab Disord       Date:  2022-03-19

2.  Interrelationship between physical activity and depression in nonalcoholic fatty liver disease.

Authors:  Ali A Weinstein; Leyla De Avila; Saisruthi Kannan; James M Paik; Pegah Golabi; Lynn H Gerber; Zobair M Younossi
Journal:  World J Hepatol       Date:  2022-03-27

3.  Hepatic-Metabolite-Based Intermittent Fasting Enables a Sustained Reduction in Insulin Resistance in Type 2 Diabetes and Metabolic Syndrome.

Authors:  Markus Rohner; Robert Heiz; Simon Feldhaus; Stefan R Bornstein
Journal:  Horm Metab Res       Date:  2021-06-30       Impact factor: 2.936

4.  The Mediation Role of the Risk of Non-Alcoholic Fatty Liver Disease in Relationship between Lutein and Zeaxanthin and Cognitive Functions among Older Adults in the United States.

Authors:  Chen Chen; Zhonghai Lu; Dongfeng Zhang; Suyun Li
Journal:  Nutrients       Date:  2022-01-28       Impact factor: 5.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.